Literature DB >> 29031577

Structural biology of GABAB receptor.

Aurel Frangaj1, Qing R Fan2.   

Abstract

Metabotropic GABAB receptor is a G protein-coupled receptor (GPCR) that mediates slow and prolonged inhibitory neurotransmission in the brain. It functions as a constitutive heterodimer composed of the GABAB1 and GABAB2 subunits. Each subunit contains three domains; the extracellular Venus flytrap module, seven-helix transmembrane region and cytoplasmic tail. In recent years, the three-dimensional structures of GABAB receptor extracellular and intracellular domains have been elucidated. These structures reveal the molecular basis of ligand recognition, receptor heterodimerization and receptor activation. Here we provide a brief review of the GABAB receptor structures, with an emphasis on describing the different ligand-bound states of the receptor. We will also compare these with the known structures of related GPCRs to shed light on the molecular mechanisms of activation and regulation in the GABAB system, as well as GPCR dimers in general. This article is part of the "Special Issue Dedicated to Norman G. Bowery".
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activation; G protein-coupled receptor; GABA(B) receptor; Heterodimer; Ligand recognition; Structure

Mesh:

Substances:

Year:  2017        PMID: 29031577      PMCID: PMC5897222          DOI: 10.1016/j.neuropharm.2017.10.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.273


  141 in total

1.  Functional interactions between the extracellular domain and the seven-transmembrane domain in Ca2+ receptor activation.

Authors:  O M Hauache; J Hu; K Ray; A M Spiegel
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

2.  A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor.

Authors:  Béatrice Duthey; Sara Caudron; Julie Perroy; Bernhard Bettler; Laurent Fagni; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

3.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.

Authors:  Daisuke Tsuchiya; Naoki Kunishima; Narutoshi Kamiya; Hisato Jingami; Kosuke Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function.

Authors:  T Galvez; B Duthey; J Kniazeff; J Blahos; G Rovelli; B Bettler; L Prézeau; J P Pin
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

5.  The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling.

Authors:  A R Calver; M J Robbins; C Cosio; S Q Rice; A J Babbs; W D Hirst; I Boyfield; M D Wood; R B Russell; G W Price; A Couve; S J Moss; M N Pangalos
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

6.  Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.

Authors:  S Urwyler; J Mosbacher; K Lingenhoehl; J Heid; K Hofstetter; W Froestl; B Bettler; K Kaupmann
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

7.  Crystal structure and association behaviour of the GluR2 amino-terminal domain.

Authors:  Rongsheng Jin; Satinder K Singh; Shenyan Gu; Hiroyasu Furukawa; Alexander I Sobolevsky; Jie Zhou; Yan Jin; Eric Gouaux
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

8.  Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.

Authors:  Erkan Karakas; Noriko Simorowski; Hiro Furukawa
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

9.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

Review 10.  Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  Darren W Engers; Craig W Lindsley
Journal:  Drug Discov Today Technol       Date:  2013
View more
  19 in total

Review 1.  Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.

Authors:  Edward A Jouney
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

2.  Interclass GPCR heteromerization affects localization and trafficking.

Authors:  Rudy Toneatti; Jong M Shin; Urjita H Shah; Carl R Mayer; Justin M Saunders; Miguel Fribourg; Paul T Arsenovic; William G Janssen; Stuart C Sealfon; Juan F López-Giménez; Deanna L Benson; Daniel E Conway; Javier González-Maeso
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 8.192

Review 3.  Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling.

Authors:  Timothy R Rose; Kevin Wickman
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca2+ ions and L-tryptophan.

Authors:  Shenglong Ling; Pan Shi; Sanling Liu; Xianyu Meng; Yingxin Zhou; Wenjing Sun; Shenghai Chang; Xing Zhang; Longhua Zhang; Chaowei Shi; Demeng Sun; Lei Liu; Changlin Tian
Journal:  Cell Res       Date:  2021-02-18       Impact factor: 46.297

Review 5.  Neurological Syndromes Associated with Anti-GAD Antibodies.

Authors:  Maëlle Dade; Giulia Berzero; Cristina Izquierdo; Marine Giry; Marion Benazra; Jean-Yves Delattre; Dimitri Psimaras; Agusti Alentorn
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

6.  Dysregulated Prefrontal Cortex Inhibition in Prepubescent and Adolescent Fragile X Mouse Model.

Authors:  Ioannis Kramvis; Rhodé van Westen; Hanna C A Lammertse; Danai Riga; Tim S Heistek; Alex Loebel; Sabine Spijker; Huibert D Mansvelder; Rhiannon M Meredith
Journal:  Front Mol Neurosci       Date:  2020-05-26       Impact factor: 5.639

Review 7.  The organizing principle of GABAB receptor complexes: Physiological and pharmacological implications.

Authors:  Thorsten Fritzius; Bernhard Bettler
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-05-15       Impact factor: 4.080

Review 8.  The GABAB Receptor-Structure, Ligand Binding and Drug Development.

Authors:  Linn Samira Mari Evenseth; Mari Gabrielsen; Ingebrigt Sylte
Journal:  Molecules       Date:  2020-07-07       Impact factor: 4.411

9.  GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer.

Authors:  Huihui Wang; Hao Zhang; Zhirong Sun; Wankun Chen; Changhong Miao
Journal:  Int J Biol Sci       Date:  2021-05-10       Impact factor: 6.580

Review 10.  Binding of clozapine to the GABAB receptor: clinical and structural insights.

Authors:  Pramod C Nair; Ross A McKinnon; John O Miners; Tarun Bastiampillai
Journal:  Mol Psychiatry       Date:  2020-03-13       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.